DK0583281T3 - Modgift - immunsera - Google Patents

Modgift - immunsera

Info

Publication number
DK0583281T3
DK0583281T3 DK92909065.2T DK92909065T DK0583281T3 DK 0583281 T3 DK0583281 T3 DK 0583281T3 DK 92909065 T DK92909065 T DK 92909065T DK 0583281 T3 DK0583281 T3 DK 0583281T3
Authority
DK
Denmark
Prior art keywords
antidote
immune sera
antivenom
species
disclosed
Prior art date
Application number
DK92909065.2T
Other languages
English (en)
Inventor
Damon Charles Smith
Original Assignee
Therapeutic Antibodies Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Therapeutic Antibodies Inc filed Critical Therapeutic Antibodies Inc
Application granted granted Critical
Publication of DK0583281T3 publication Critical patent/DK0583281T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/02—Antidotes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/804—Drug, bio-affecting and body treating compositions involving IgG3, IgG4, IgA, or IgY
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S424/00—Drug, bio-affecting and body treating compositions
    • Y10S424/809—Drug, bio-affecting and body treating compositions involving immunoglobulin or antibody fragment, e.g. fab', fv, fc, heavy chain or light chain
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/855—Proteins from animals other than mammals or birds
    • Y10S530/856—Snakes; venom
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/866—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving immunoglobulin or antibody fragment, e.g. fab', fab, fv, fc, heavy chain or light chain

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Nonwoven Fabrics (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Medical Preparation Storing Or Oral Administration Devices (AREA)
  • Fats And Perfumes (AREA)
  • Packages (AREA)
  • Peptides Or Proteins (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
DK92909065.2T 1991-05-02 1992-04-24 Modgift - immunsera DK0583281T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB919109478A GB9109478D0 (en) 1991-05-02 1991-05-02 Antivenoms

Publications (1)

Publication Number Publication Date
DK0583281T3 true DK0583281T3 (da) 1997-08-25

Family

ID=10694329

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92909065.2T DK0583281T3 (da) 1991-05-02 1992-04-24 Modgift - immunsera

Country Status (12)

Country Link
US (1) US6833131B1 (da)
EP (1) EP0583281B1 (da)
JP (1) JP3666872B2 (da)
AT (1) ATE155345T1 (da)
AU (1) AU672172B2 (da)
DE (1) DE69220939T2 (da)
DK (1) DK0583281T3 (da)
ES (1) ES2106183T3 (da)
GB (2) GB9109478D0 (da)
GR (1) GR3024907T3 (da)
RU (1) RU2114636C1 (da)
WO (1) WO1992019280A1 (da)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2222993A1 (en) * 1998-02-04 1999-08-04 The Ontario Cancer Institute A method for using a ribosome-inactivating protein complex as a structural template and a molecular search engine in the design, construction and screening of combinatorial protein libraries
US6709655B2 (en) 2001-02-28 2004-03-23 Instituto Bioclon, S.A. De C.V. Pharmaceutical composition of F(ab1)2 antibody fragments and a process for the preparation thereof
ES2493465T3 (es) * 2005-09-26 2014-09-11 Molecular Templates, Inc. Biblioteca a partir de toxinas mutantes y procesos de utilización de la misma
CN101385855B (zh) * 2006-05-19 2011-11-16 成都军区疾病预防控制中心昆明军事医学研究所 精制多价抗蛇毒冻干血清的方法
CN101347617B (zh) * 2006-06-02 2011-04-06 成都军区疾病预防控制中心军事医学研究所 精制多价抗蛇毒冻干血清及使用方法
TW201132759A (en) 2009-12-18 2011-10-01 Sanofi Aventis Novel antagonist antibodies and their FaB fragments against GPVI and uses thereof
CN106243224A (zh) * 2016-08-05 2016-12-21 安徽威尔试剂盒科技有限责任公司 一种利用尖吻蝮蛇毒特异蛋白制备抗血清的方法及其应用
CN106008713A (zh) * 2016-08-05 2016-10-12 安徽威尔试剂盒科技有限责任公司 一种尖吻蝮蛇毒高效价抗血清的制备方法及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5053492A (en) * 1986-08-07 1991-10-01 Board Of Regents, The University Of Texas System Immunopurification using monoclonal antibodies to Mojave toxin
US4806346A (en) * 1986-12-16 1989-02-21 American Home Products Corporation Method for isolation of antigen specific immunoglobulin
DE3920713A1 (de) 1989-06-24 1991-01-10 Bosch Gmbh Robert Insassen-sicherheitseinrichtung fuer fahrzeuge
US5196193A (en) * 1989-10-31 1993-03-23 Ophidian Pharmaceuticals, Inc. Antivenoms and methods for making antivenoms

Also Published As

Publication number Publication date
JPH06506928A (ja) 1994-08-04
GB9109478D0 (en) 1991-06-26
DE69220939D1 (de) 1997-08-21
GB2271509A (en) 1994-04-20
GB9322377D0 (en) 1994-02-09
AU1677492A (en) 1992-12-21
EP0583281A1 (en) 1994-02-23
AU672172B2 (en) 1996-09-26
RU2114636C1 (ru) 1998-07-10
ES2106183T3 (es) 1997-11-01
DE69220939T2 (de) 1997-11-20
JP3666872B2 (ja) 2005-06-29
GB2271509A8 (en) 2000-03-27
GB2271509B (en) 1995-03-08
EP0583281B1 (en) 1997-07-16
GR3024907T3 (en) 1998-01-30
US6833131B1 (en) 2004-12-21
WO1992019280A1 (en) 1992-11-12
ATE155345T1 (de) 1997-08-15

Similar Documents

Publication Publication Date Title
DE122009000012I1 (de) Substituierte pyrazolyl-benzolsulfonamide zur behandlung von entzundungen.
DE3586959T2 (de) Desinfektionsverfahren sowie zusammensetzung dafuer.
FI941133A0 (fi) Koostumus ja menetelmä hepatiitti C:n hoitamiseksi
DE68912237T2 (de) Dampfsensitive Zusammensetzung sowie diese enthaltende sterilisierungsanzeigende Zusammensetzung.
DE69010893D1 (de) Verfahren zur behandlung von koks sowie löschen desselben.
DE69430903T2 (de) Behandlung von periodontitis mit misoprostol
FI950587A0 (fi) Endotoksiinimyrkytyksen ennaltaehkäisyssä ja hoidossa käyttökelpoisia menetelmiä
ATE168268T1 (de) Behandlung von menschlichen retrovirus- infektionen mit 2',3'-dideoxyinosin
EP0206529A3 (en) Treatment of oral diseases
DE69434223D1 (de) In der behandlung von il4 auslösenden krankheiten nützliche rekombinante il4 antikörper
DE59402794D1 (de) Strahlungsempfindliches Gemisch und Verfahren zur Herstellung von Reliefstrukturen mit verbessertem Kontrast
DE68919172T2 (de) MOSFET und dessen Herstellungsverfahren.
DE68917433T2 (de) Verfahren zur behandlung von asbest sowie asbestbehandlungsmittel.
DK0583281T3 (da) Modgift - immunsera
DE3381624D1 (de) Mittel zur behandlung von wunden.
DE58906239D1 (de) Einrichtung zur Behandlung von Erkrankungen, insbesondere der Sehbahn.
DE58902899D1 (de) 2',3'-dideoxypurinnucleosid/purinnucleosid-phosphorylase-inhibitor kombinationstherapie und zusammensetzungen dafuer.
DE68911776D1 (de) Konjugierte Oxybutenolide zur Behandlung von Ulcera.
DK67683A (da) Fremgangsmaade til fremstilling af 2,3-diaryl-5-halogen-thio-phener
NO894008D0 (no) Trekonserveringsmiddel og fremgangsmaate for behandling avtre med samme.
DE69412178T2 (de) Apparat zur Behandlung von Lagen
DE3884652D1 (de) Gate-Ausschaltthyristor und Verfahren zu dessen Herstellung.
DE3878529D1 (de) Vorrichtung zur behandlung von verstauchungen, insbesondere der sprunggelenke sowie zur vermeidung von dabei auftretenden bestimmten komplikationen.
IT8224010A0 (it) Perfezionamento ai rubinetti d'intercettazione e di ritegno.
NO904614D0 (no) Sementbindingsakselerator og fremgangsmaate for fremstilling av den samme.